Amundi Asset Management US’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $2.6M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|
|||||
|
2020
Q2 | $1.81M | Buy |
|
|||||
|
2020
Q1 | $981K | Sell |
|
|||||
|
2019
Q4 | $1.25M | Buy |
|
|||||
|
2019
Q3 | $697K | Sell |
|
|||||
|
2019
Q2 | $976K | Buy |
|
|||||
|
2019
Q1 | $1.6M | Buy |
|
|||||
|
2018
Q4 | $1.42K | Buy |
|
|||||
|
2018
Q3 | $1.59M | Buy |
|
|||||
|
2018
Q2 | $1.76M | Buy |
|
|||||
|
2018
Q1 | $1.22M | Buy |
|
|||||
|
2017
Q4 | $1.12M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $23.3M | Sell |
|
|||||
|
2015
Q3 | $92.6M | Buy |
|
|||||
|
2015
Q2 | $68.3M | Buy |
|
|||||
|
2015
Q1 | $71.5M | Buy |
|
|||||
|
2014
Q4 | $59.6M | Buy |
|
|||||
|
2014
Q3 | $12.8M | Buy |
|
|||||
|
2014
Q2 | $11.9M | Buy |
|
|||||
|
2014
Q1 | $942K | Sell |
|
|||||
|
2013
Q4 | $3.14M | Sell |
|
|||||
|
2013
Q3 | $32.2M | Buy |
|
|||||
|
2013
Q2 | $29.9M | Buy |
|